WO2002069936A2 - Composition pharmaceutique amelioree d'ibuprofene et procede de production de telles compositions - Google Patents

Composition pharmaceutique amelioree d'ibuprofene et procede de production de telles compositions Download PDF

Info

Publication number
WO2002069936A2
WO2002069936A2 PCT/IB2002/000534 IB0200534W WO02069936A2 WO 2002069936 A2 WO2002069936 A2 WO 2002069936A2 IB 0200534 W IB0200534 W IB 0200534W WO 02069936 A2 WO02069936 A2 WO 02069936A2
Authority
WO
WIPO (PCT)
Prior art keywords
acid
composition
ibuprofen
active ingredient
soft gelatin
Prior art date
Application number
PCT/IB2002/000534
Other languages
English (en)
Other versions
WO2002069936A3 (fr
Inventor
Prashant Manohar Mandaogade
Ujwal Damu Kolhe
Abhijit Mukund Deshmukh
Mailatur Sivaraman Mohan
Original Assignee
Dr. Reddy's Laboratories Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Reddy's Laboratories Ltd. filed Critical Dr. Reddy's Laboratories Ltd.
Priority to AU2002244865A priority Critical patent/AU2002244865A1/en
Publication of WO2002069936A2 publication Critical patent/WO2002069936A2/fr
Publication of WO2002069936A3 publication Critical patent/WO2002069936A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Abstract

L'invention concerne un principe actif, l'ibuprofène ou (S)(+)-ibuprofène en tant que base libre ou en tant que sels de métal alcalin, ou que de mélanges desdits composants, sous forme d'une capsule en gélatine molle, lesdites capsules en gélatine molle présentant une composition de masse de gel de capsule en gélatine molle permettant de favoriser la solubilisation du principe actif. L'invention concerne également le procédé de production d'une telle capsule en gélatine molle ou d'une telle composition de masse de gel de gélatine molle. Un autre aspect de l'invention permet d'éviter l'utilisation de polyéthylène glycol ou d'espèces d'ions hydroxydes contenant des solvants en tant que solubilisateurs, pour la préparation de capsules en gélatine molle contenant ledit principe actif.
PCT/IB2002/000534 2001-03-02 2002-02-22 Composition pharmaceutique amelioree d'ibuprofene et procede de production de telles compositions WO2002069936A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002244865A AU2002244865A1 (en) 2001-03-02 2002-02-22 Pharmaceutical composition of ibuprofen

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN187MA2001 2001-03-02
IN187/MAS/2001 2001-03-02
IN204/MAS/2001 2001-03-07
IN204MA2001 2001-03-07

Publications (2)

Publication Number Publication Date
WO2002069936A2 true WO2002069936A2 (fr) 2002-09-12
WO2002069936A3 WO2002069936A3 (fr) 2003-02-20

Family

ID=26324890

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2002/000534 WO2002069936A2 (fr) 2001-03-02 2002-02-22 Composition pharmaceutique amelioree d'ibuprofene et procede de production de telles compositions

Country Status (2)

Country Link
AU (1) AU2002244865A1 (fr)
WO (1) WO2002069936A2 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2404336A (en) * 2003-07-30 2005-02-02 Cipla Ltd Stabilisation of therapeutic agents using a carbonate salt of an amino acid, preferably in the presence of a saccharide, & pharmaceutical compositions thereof
WO2005063219A2 (fr) * 2003-12-23 2005-07-14 Ranbaxy Laboratories Limited Capsules en gelatine molle contenant de l'ibuprofene
WO2008005742A2 (fr) * 2006-06-30 2008-01-10 Mcneil-Ppc, Inc. Capsules dures emplies d'un liquide contenant de l'ibuprofène
WO2008052033A2 (fr) * 2006-10-25 2008-05-02 Mcneil-Ppc, Inc. Composition d'ibuprofène
WO2009069139A1 (fr) * 2007-11-28 2009-06-04 Alkem Laboratories Ltd. Forme posologique fournissant un remplissage liquide contenant de l'ibuprofène
CN102204882A (zh) * 2011-03-22 2011-10-05 韩彬 布洛芬的药物组合物
US10966926B2 (en) 2010-04-14 2021-04-06 Vitux Group As Oral pharmaceutical dispersion compositions

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6067676B2 (ja) * 2011-04-11 2017-01-25 アヤンダ グループ エーエス 経口医薬分散組成物

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4834966A (en) * 1986-08-01 1989-05-30 Zambon S.P.A. Pharmaceutical composition with analgesic activity
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US5645856A (en) * 1994-03-16 1997-07-08 R. P. Scherer Corporation Delivery systems for hydrophobic drugs
WO1998038984A2 (fr) * 1997-03-05 1998-09-11 Sugen, Inc. Preparations d'agents pharmaceutiques hydrophobes
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
GB2331458A (en) * 1997-11-21 1999-05-26 Gursharan Singh Moonga Solvent compositions for gelatin capsules

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4834966A (en) * 1986-08-01 1989-05-30 Zambon S.P.A. Pharmaceutical composition with analgesic activity
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US5645856A (en) * 1994-03-16 1997-07-08 R. P. Scherer Corporation Delivery systems for hydrophobic drugs
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
WO1998038984A2 (fr) * 1997-03-05 1998-09-11 Sugen, Inc. Preparations d'agents pharmaceutiques hydrophobes
GB2331458A (en) * 1997-11-21 1999-05-26 Gursharan Singh Moonga Solvent compositions for gelatin capsules

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2404336A (en) * 2003-07-30 2005-02-02 Cipla Ltd Stabilisation of therapeutic agents using a carbonate salt of an amino acid, preferably in the presence of a saccharide, & pharmaceutical compositions thereof
WO2005063219A2 (fr) * 2003-12-23 2005-07-14 Ranbaxy Laboratories Limited Capsules en gelatine molle contenant de l'ibuprofene
WO2005063219A3 (fr) * 2003-12-23 2005-08-11 Ranbaxy Lab Ltd Capsules en gelatine molle contenant de l'ibuprofene
WO2008005742A2 (fr) * 2006-06-30 2008-01-10 Mcneil-Ppc, Inc. Capsules dures emplies d'un liquide contenant de l'ibuprofène
WO2008005742A3 (fr) * 2006-06-30 2008-07-10 Mcneil Ppc Inc Capsules dures emplies d'un liquide contenant de l'ibuprofène
WO2008052033A2 (fr) * 2006-10-25 2008-05-02 Mcneil-Ppc, Inc. Composition d'ibuprofène
WO2008052033A3 (fr) * 2006-10-25 2008-06-12 Mcneil Ppc Inc Composition d'ibuprofène
WO2009069139A1 (fr) * 2007-11-28 2009-06-04 Alkem Laboratories Ltd. Forme posologique fournissant un remplissage liquide contenant de l'ibuprofène
US10966926B2 (en) 2010-04-14 2021-04-06 Vitux Group As Oral pharmaceutical dispersion compositions
CN102204882A (zh) * 2011-03-22 2011-10-05 韩彬 布洛芬的药物组合物
CN102204882B (zh) * 2011-03-22 2013-07-24 韩彬 布洛芬的药物组合物

Also Published As

Publication number Publication date
WO2002069936A3 (fr) 2003-02-20
AU2002244865A1 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
US11896566B2 (en) Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
WO2004071490A1 (fr) Systeme de solvants de medicament a peine soluble a taux d'elution ameliore
JP6209495B2 (ja) 上部消化管治療用医薬製剤
TW200302734A (en) Pharmaceutical compositions for hepatitis c viral protease inhibitors
JP2010523673A (ja) メラトニンタブレットならびに調剤及び使用方法
JP2010532336A (ja) 水分散性の乾いた形態の医薬品の新規製造方法およびそれに伴い得られる医薬組成物
JP2008534586A (ja) フェノフィブレートの改良された製剤
JP2008505934A (ja) メンソール又はｐｅｇ／ポロキサマーを含むフェノフィブレートの改良された製剤
JP2004525164A (ja) ４−シアノ−トリフルオロ−３−（４−フルオロフェニルスルホニル）−２−ヒドロキシ−２−メチルプロピオノ−ｍ−トルイジドとＰＶＰを含む固体医薬組成物
JPH07196512A (ja) 医薬組成物
WO2002069936A2 (fr) Composition pharmaceutique amelioree d'ibuprofene et procede de production de telles compositions
JP5788534B2 (ja) フェニルアミノピリミジン誘導体を活性薬剤として含む製剤
ES2342825T3 (es) Solucion de ibuprofeno para capsulas de cubierta dura.
WO2016140933A2 (fr) Compositions d'ibuprofène solubles à libération immédiate
KR101859200B1 (ko) 모노아세틸디아실글리세롤 화합물의 경구 투여용 조성물 및 고형 제제
US20040146537A1 (en) Oily wax matrix suspension formulation comprising pharmacologically active agents
JP2001240558A (ja) 多価不飽和脂肪酸を経粘膜吸収促進剤として含有する固形製剤。
JP2014513710A (ja) ケトプロフェンを含む医薬組成物
CA3207235A1 (fr) Formulations de gel liquide concentrees contenant des sels de naproxene
KR100986531B1 (ko) 액상의 아세클로페낙을 함유하는 캡슐제
TW201309286A (zh) 包含酮洛芬（ｋｅｔｏｐｒｏｆｅｎ）的醫藥組合物

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP